New Evidence For An Adp-Independent Mechanism Of Thrombin Induced Platelet Activation

1981 ◽  
Author(s):  
W R Figures ◽  
R F Colman ◽  
S Niewiarowski ◽  
T Morinelli ◽  
Y Wachtfogel ◽  
...  
Keyword(s):  
Shape Change ◽  
Fibrinogen Binding ◽  
Sds Page ◽  
Independent Mechanism ◽  
Human Thrombin ◽  
Induced Aggregation ◽  
New Evidence ◽  
Adenosine Nucleotide ◽  
Platelet Shape

The adenosine nucleotide analog, 5’fluorosulfonylbenzoyl adenosine (5’FSBA) is a potent inhibitor of ADP induced platelet shape change, aggregation, and fibrinogen binding and covalently incorporates into a single membrane polypeptide (Mr=100,000). To evaluate the role of released intracellular ADP in thrombin induced aggregation and fibrinogen binding, the effects of 5’FSBA on these events were studied. Following incubation with 5’FSBA, the platelets became unresponsive to ADP but were aggregated by purified human thrombin (0.2 U/ml). However, the aggregation was slower and less extensive than that of untreated control platelets. Binding of 125I-fibrinogen to control platelets occured after exposure to ADP or after exposure to thrombin in the presence of hirudin to inhibit clotting. Binding of 125I-fibrinogen was absent in platelets treated with 5’FSBA after exposure to ADP and diminished after incubation with thrombin (0.2 U/ml, 5 min.).The effect of thrombin on the single platelet membrane polypeptide modified by 5’FSBA was examined by SDS-PAGE. Thrombin treatment (0.5 U/ml, 30 min.) of cells labeled with (H)-5’FSBA resulted in partial cleavage of this polypeptide as evident by a decrease in the (H) FSBA-modified polypeptide in the thrombin treated samples as compared to controls. Unlike chymotrypsin activation of platelets, no fragment of the protein at 75,000 daltons was associated with the membranes of thrombin treated cells. The results of these experiments indicate that thrombin induced platelet aggregation and fibrinogen binding depend on both ADP binding which is blocked by 5’FSBA and the proteolytic cleavage of the same 100,000 dalton membrane polypeptide cleaved by chymotrypsin.

Proteolysis of the platelet surface: dissociation of shape change from aggregation

1986 ◽  
Vol 250 (4) ◽  
pp. H550-H557
Author(s):  
E. Kornecki ◽  
Y. H. Ehrlich ◽  
D. H. Hardwick ◽  
R. H. Lenox
Keyword(s):  
Adenylate Cyclase ◽  
Binding Sites ◽  
Prostaglandin E1 ◽  
Direct Evidence ◽  
Shape Change ◽  
Adenylate Cyclase System ◽  
Platelet Surface ◽  
Fibrinogen Binding ◽  
Induced Aggregation ◽  
Platelet Shape

Stimulation of intact platelets by ADP results in a shape change followed by aggregation in the presence of fibrinogen. ADP was found to induce a shape change in chymotrypsin-treated platelets that was similar in extent and initial velocity to that of intact (untreated) platelets. Scanning-electron microscopy verified an ADP-induced shape change in chymotrypsin-treated platelets. This shape change could be completely blocked by stimulators of platelet adenylate cyclase (forskolin, prostaglandin E1, and prostacyclin). On the other hand, the aggregation of chymotrypsin-treated platelets by fibrinogen was not dependent on the presence of ADP and could not be blocked by forskolin, prostaglandin E1, or prostacyclin, even though the levels of cyclic AMP (cAMP) formed in chymotrypsin-treated platelets were comparable to levels that completely inhibited the ADP-induced aggregation of intact platelets. This lack of inhibition of platelet aggregation was not due to degradation of the adenylate cyclase or prostaglandin receptors, since chymotrypsin-treated platelets were found to have a functional adenylate cyclase system that could be stimulated by forskolin, prostaglandin E1, and prostacyclin and inhibited by ADP and epinephrine, similar to that of intact platelets. These results provide direct evidence that cAMP does not interact with fibrinogen binding sites once they have become permanently exposed on the surface of platelets. Pretreatment of platelets with chymotrypsin therefore appears to be a useful tool that allows for the dissociation of platelet shape change from aggregation, without inhibiting either response.

The Actin Regulator Coronin-1A Modulates Platelet Shape Change and Consolidates Arterial Thrombosis

2018 ◽  
Vol 118 (12) ◽  
pp. 2098-2111 ◽  
Author(s):  
Thomas Stocker ◽  
Joachim Pircher ◽  
Artid Skenderi ◽  
Andreas Ehrlich ◽  
Clemens Eberle ◽  
...  
Keyword(s):  
Arterial Thrombosis ◽  
Actin Polymerization ◽  
Thrombus Formation ◽  
Shape Change ◽  
Actin Binding ◽  
Cellular Processes ◽  
Reduced Density ◽  
Induced Aggregation ◽  
Platelet Shape

AbstractCoronin-1A (Coro1A) belongs to a family of highly conserved actin-binding proteins that regulate cytoskeletal re-arrangement. In mammalians, Coro1A expression is most abundant in the haematopoietic lineage, where it regulates various cellular processes. The role of Coro1A in platelets has been previously unknown. Here, we identified Coro1A in human and mouse platelets. Genetic absence of Coro1A in mouse platelets inhibited agonist-induced actin polymerization and altered cofilin phosphoregulation, leading to a reduction in spreading and low-dose collagen induced aggregation. Furthermore, Coro1A-deficient mice displayed a defect in ferric chloride-induced arterial thrombosis with prolonged thrombus formation and reduced thrombus size. Immunofluorescence analysis revealed a less compact thrombus structure with reduced density of platelets and fibrinogen. In summary, Coro1A has a role in platelet biology with impact on spreading, aggregation and thrombosis.

Platelet Aggregation Caused by Dithiothreitol

1984 ◽  
Vol 51 (01) ◽  
pp. 119-124 ◽  
Author(s):  
M B Zucker ◽  
N C Masiello
Keyword(s):  
Shape Change ◽  
Blood Platelets ◽  
Dense Granule ◽  
Metabolic Inhibitors ◽  
Electrophoretic Patterns ◽  
Discernible Effect ◽  
Variable Extent ◽  
Triton X ◽  
Induced Aggregation ◽  
Platelet Shape

SummaryMacIntyre et al. showed that over 1 mM dithiothreitol (DTT) aggregates blood platelets in the presence of fibrinogen; aggregation is not inhibited by prostaglandin E1. We confirmed their data and found that 70 mM 2-mercaptoethanol was also active. DTT- induced aggregation was not associated with platelet shape change or secretion of dense granule contents, was not inhibited by tetracaine or metabolic inhibitors, was prevented at pH 6.5, and prevented, reversed, or arrested by EDTA, depending on when the EDTA was added. DTT did not cause aggregation of thrombasthenic, EDTA-treated, or cold (0° C) platelets, which also failed to aggregate with ADP. Platelets stimulated with DTT bound 125I-labeled fibrinogen. Thus DTT appears to “expose” the fibrinogen receptors. SDS gel electrophoresis of platelet fractions prepared by use of Triton X-114 showed that aggregating concentrations of DTT reduced proteins of apparent Mr 69,000 and 52,000 (probably platelet albumin) and, to a variable extent, glycoproteins Ib, IIb and III. Exposure of unlabeled or 125I- labeled platelets to ADP had no discernible effect on the electrophoretic patterns.

Possible Differences In The Mode Of Action Of Ditazole And Non-Steroidal Anti-Inflammatory Drugs As Potential Antithrombotic Agents

1981 ◽  
Author(s):  
A K Sim ◽  
A P McCraw ◽  
L Caprino ◽  
F Antonetti ◽  
L Morelli
Keyword(s):  
Platelet Aggregation ◽  
Mode Of Action ◽  
Platelet Rich Plasma ◽  
Shape Change ◽  
Dose Range ◽  
Oral Drug ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
Induced Aggregation ◽  
Platelet Shape

Ditazole (4,5-diphenyl-2-diethanolamino-oxazole), a weak anti-inflammatory drug, has been shown to be a potent inhibitor of platelet aggregation, adhesiveness and bleeding time. Acetylsalicylic acid (ASA), dipyridamole and a combination of these two drugs induced a platelet shape change which was much shorter lasting than their effect on platelet aggregation. Conversely, similar doses of ditazole induced a potent shape change but no effect on aggregation. Ditazole has now been shown to reversibly antagonise thromboxane A2 (TXA2)-induced contraction of rabbit aortic strips at an optimal concentration of 25 μm in the perfusate. Separately, over a dose range of 50-400 mg/kg/p.o., TXA2 production was inhibited between 39% and 85% in spontaneously clotted rabbit blood. In addition, we have shown that TXA2 formation following arachidonic acid-induced aggregation of platelet-rich plasma (PRP) is similarly inhibited. Ditazole however did not inhibit prostacyclin (PGI2) production in rabbit aortic rings following oral drug administration over a dose range of 50-400 mg/kg. At 1000 and 2000 mg/kg PGI2 production was inhibited by 23% and 41% respectively. TXA2 and PGI2 levels were measured by radioimmunoassay of their stable derivatives TXB2 and 6-keto-PGF1α. It is suggested that the mode of action of ditazole may be more specific than the cyclo-oxygenase/PG-synthetase blocking activity of most other non-steroidal anti-inflammatory drugs.

Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion

1989 ◽  
Vol 56 (2) ◽  
pp. 299-306 ◽  
Author(s):  
Tohru Nakano ◽  
Kohji Hanasaki ◽  
Hitoshi Arita
Keyword(s):  
Protein Kinase C ◽  
Protein Kinase ◽  
Shape Change ◽  
Kinase C ◽  
Platelet Shape

scholarly journals The effect of aggregation and release on platelet prothrombin- converting activity

Blood ◽  
1979 ◽  
Vol 54 (3) ◽  
pp. 659-672 ◽  
Author(s):  
AC Cox ◽  
P Inyangetor ◽  
CT Esmon ◽  
BN White
Keyword(s):  
Platelet Aggregation ◽  
Prostaglandin E1 ◽  
Dense Body ◽  
Shape Change ◽  
Factor Xa ◽  
Dense Bodies ◽  
Activated Platelets ◽  
Induced Aggregation ◽  
Body Secretion ◽  
Platelet Shape

Abstract Platelets provide a procoagulant activity for the conversion of prothrombin to thrombin during normal hemostatis. This activity designated as platelet prothrombin-converting activity (PPCA) was monitored as rate of thrombin production in a two-stage assay using gel- filtered bovine platelets, factor Xa, and prothrombin. Expression of PPCA was not associated with ADP-induced release or platelet shape change but was associated with aggregation. Release of the contents of dense bodies, measured by release of 14C-5-hydroxytryptamine, was not required for expression of PPCA during platelet aggregation. During the PPCA assay, 5-hydroxytrypamine was released, but only after onset of thrombin production. Furthermore, the release of 5-hydroxytryptamine was retarded during the assay by the addition of 2 mM theophylline and 100 nM prostaglandin E1 without a comparable reduction in PPCA. In addition, 125I-factor-Xa was bound in greater amounts to platelets (aspirin-treated) after ADP-induced aggregation (without detectable release) than to unactivated control platelets. Finally, the PPCA of the ADP-activated platelets was saturated with respect to factors Xa and Va at less than 1 nM concentrations, indicating that the aggregation induced by ADP leads to the exposure of specific procoagulant sites by some process other than dense body secretion.

Roles of SLP-76, phosphoinositide 3-kinase, and gelsolin in the platelet shape changes initiated by the collagen receptor GPVI/FcRγ-chain complex

Blood ◽  
2000 ◽  
Vol 96 (12) ◽  
pp. 3786-3792 ◽  
Author(s):  
Hervé Falet ◽  
Kurt L. Barkalow ◽  
Vadim I. Pivniouk ◽  
Michael J. Barnes ◽  
Raif S. Geha ◽  
...  
Keyword(s):  
Platelet Activation ◽  
Shape Change ◽  
Chain Complex ◽  
Actin Assembly ◽  
Coated Surface ◽  
Phosphoinositide 3 Kinase ◽  
Collagen Receptor ◽  
Shape Changes ◽  
Platelet Shape

Abstract How platelet shape change initiated by a collagen-related peptide (CRP) specific for the GPVI/FcRγ-chain complex (GPVI/FcRγ-chain) is coupled to SLP-76, phosphoinositide (PI) 3-kinase, and gelsolin is reported. As shown by video microscopy, platelets rapidly round and grow dynamic filopodial projections that rotate around the periphery of the cell after they contact a CRP-coated surface. Lamellae subsequently spread between the projections. All the actin-driven shape changes require SLP-76 expression. SLP-76 is essential for the Ca++mobilization induced by CRP, whereas PI 3-kinase only modulates it. The extension of lamellae requires net actin assembly and an exposure of actin filament barbed ends downstream of PI 3-kinase. Gelsolin expression is also required for the extension of lamellae, but not for the formation of filopodia. Altogether, the data describe the role of SLP-76 in the platelet activation initiated by GPVI/FcRγ-chain and the roles of PI 3-kinase and gelsolin in lamellae spreading.

scholarly journals Changes in phosphatidylinositol-4,5-bisphosphate 10 seconds after stimulation of washed rabbit platelets with ADP

Blood ◽  
1982 ◽  
Vol 60 (6) ◽  
pp. 1247-1250
Author(s):  
JD Vickers ◽  
RL Kinlough-Rathbone ◽  
JF Mustard
Keyword(s):  
Shape Change ◽  
Adenosine Diphosphate ◽  
Cellular Responses ◽  
Release Reaction ◽  
Rabbit Platelets ◽  
Induced Aggregation ◽  
Platelet Shape ◽  
Stimulation Of

Adenosine diphosphate (ADP) induced aggregation of rabbit platelets, without the release reaction, causes a significant decrease (7%) in the amount of phosphatidylinositol-4,5-bisphosphate (PIP2) at 10 sec and at 60 sec (11%). In platelets prelabeled with 32P-phosphate, this decrease in PIP2 is associated with a decrease in PIP2 radioactivity, which is significant at 50 sec. The decrease in PIP2 is sufficient to mobilize about 0.18 nmole Ca2+/10(9) platelets. In view of the key role played by Ca2+ in ADP-induced platelet shape change and aggregation, this evidence is compatible with the hypothesis that changes in PIP2 can be a source of calcium for cellular responses to agonists.

Sign in / Sign up

Export Citation Format

Share Document